Literature DB >> 7981334

Improvements in creatinine methodology: a critical assessment.

B G Blijenberg1, H J Brouwer, T J Kuller, R Leeneman, C J van Leeuwen.   

Abstract

A large evaluation study, analytical as well as clinical, was performed on four published improvements for the determination of creatinine in serum. Two of the methods were based on the Jaffé reaction, the other two were enzymatic methods. Analytically, all four methods showed a similar performance. In the analysis of numerous specimens from advanced care departments, however, the methods performed differently. The two enzymatic procedures scored better than the two Jaffé methods, when compared with an HPLC-based reference method. However, even the best methods produced outliers and a larger scatter than that obtained with "normal" specimens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981334     DOI: 10.1515/cclm.1994.32.7.529

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  5 in total

Review 1.  Essentials of laboratory medicine for the nephrology clinician.

Authors:  Tarak Srivastava; Uttam Garg; Y Raymond Chan; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2006-09-01       Impact factor: 3.714

2.  Method evaluation of an enzymatic method for serum creatinine.

Authors:  K S Saibaba; P V Srinivasa Rao; K V Dakshina Murty; M V Bhaskar
Journal:  Indian J Clin Biochem       Date:  1997-07

3.  Evaluating estimated glomerular filtration rates of creatinine and cystatin C for male patients with chronic spinal cord injury.

Authors:  Takuro Goto; Yoshihide Kawasaki; Jun Takemoto; Yuko Abe; Takashige Namima
Journal:  Spinal Cord       Date:  2018-01-10       Impact factor: 2.772

Review 4.  Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate.

Authors:  Pierre Delanaye; Etienne Cavalier; Jean-Paul Cristol; Joris R Delanghe
Journal:  J Nephrol       Date:  2014-04-08       Impact factor: 3.902

5.  Retrospective cohort study on the safety and efficacy of docetaxel in Japanese non-small cell lung cancer patients with nondialysis chronic kidney disease stage 3b or higher.

Authors:  Satoshi Anai; Ritsu Ibusuki; Tomoaki Takao; Yuko Sakurai; Junko Hisasue; Yoichi Takaki; Naohiko Hara
Journal:  Thorac Cancer       Date:  2019-10-21       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.